May 8, 2022
Scientists engineer a bacteria to produce a drug used to treat Parkinson’s disease
Posted by Gemechu Taye in categories: biotech/medical, engineering, genetics, neuroscience
The results of the study could lead to new treatment options. In a groundbreaking new study published in the journal Nature on Thursday, researchers have compared the brain cells of patients who had died from either Parkinson’s disease or dementia to people unaffected by the disorders and found which brain cells are responsible for both conditions.
A team of researchers has created a bacteria that can produce a steady and consistent source of medicine inside a patient’s gut, suggesting the possibility for genetically edited bacteria to be an efficient Parkinson’s disease treatment.